Better Life Through
Better Medicine
Caring for Health, Advancing Innovation
Pioneering high-quality oncology injectables that go a step beyond standard generics — expanding patient access to affordable, life-saving treatment.
Oncology Leadership
Leading Innovation in Oncology
Areva™ specializes in delivering high-quality oncology injectables that go a step beyond standard generics.
We are developing a wide variety of products that address the needs of traditional chemotherapy, ensuring that patients have greater access to affordable treatment.
Addressing Critical Drug Shortages
Areva™ is positioned to address critical drug shortages while building long-term relationships in the pharmaceutical market.
Oncology Expertise
Specializing in high-quality oncology injectables
Quality Assured
Products that go beyond standard generics
Safety First
Meeting the highest safety standards in pharmaceutical production
Addressing Critical Drug Shortages
Areva™ is positioned to address critical drug shortages while building long-term relationships in the pharmaceutical market.
Oncology Expertise
Specializing in high-quality oncology injectables developed under the most stringent quality and safety protocols in the industry.
Patient Access
Ensuring greater access to affordable cancer treatment through our ArevaCares Program, reaching patients who need it most.
Product Portfolio
Our Product Portfolio
Comprehensive oncology solutions designed to provide accessible, high-quality treatment options for patients worldwide
Oncology Injectables
High-quality injectable chemotherapy solutions manufactured under stringent safety protocols
Specialty Formulations
Innovative pharmaceutical formulations addressing specific oncology treatment needs
Our Products
High-Quality Injectable Solutions
High-quality injectable pharmaceutical solutions for oncology and supportive care
Product Pipeline
Advancing Oncology Care Through Continuous Innovation
Advancing oncology care through continuous innovation and development of high-quality pharmaceutical solutions
Fludarabine Phosphate 50mg/2mL
Chronic Lymphocytic Leukemia, CART Therapy
Caspofungin 50mg & 70mg
Invasive Fungal Infections
Furosemide Injectable
Loop Diuretic
Verapamil Injectable
Cardiovascular Support
Bupivacaine Injectable
Local Anesthesia
Terbutaline Injectable
B2 Agonist, Bronchodilator Therapy
Pamidronate Disodium Injectable
Hypercalcemia & Bone Metastases
Areva P0013 Q4 2026
505b2 Filing
Areva P0014 Q2 2027
Patent Pending
Future Development
Interested in learning to license a product? Contact our BD team for licensing opportunities and partnerships
Contact BD TeamManufacturing Excellence
World-Class Manufacturing
Given the high degree of toxicity in the production process, producing high-quality, safe oncology injectables is a challenging task.
Our Commitment
Areva™ has more than met this challenge by committing significant resources towards manufacturing facilities that are the most advanced in the world.
- State-of-the-art manufacturing facilities
- Advanced technology for high-toxicity production
- World-class quality control systems
- ISO-certified production processes
- Stringent safety protocols
- Continuous innovation and improvement
Leadership Team
Our Leadership Team
Our experienced leadership team brings decades of pharmaceutical industry expertise to advance oncology care and address critical drug shortages.
Irene S. Kang
Victor Swaminathan
Scott Cormiea
Mark Windley
Jim Eveslage
Dr. Sekhar Ayappanee
Get in Touch
Have Questions? We're Here
Have questions about our products or services? We're here to help.
Georgetown, IN 47122
Helpful Resources
🏛 U.S. Food & Drug Administration (FDA)Our Partners
